QuadMedicine, Inc. (KOSDAQ:464490)
South Korea
· Delayed Price · Currency is KRW
16,220
+320 (2.01%)
At close: Mar 6, 2026
QuadMedicine Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 |
| Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Debt / Equity Ratio | 1.15 | 0.64 | 0.72 |
| Net Debt / Equity Ratio | 0.48 | -0.25 | 0.22 |
| Net Debt / EBITDA Ratio | -1.87 | 2.24 | -0.26 |
| Net Debt / FCF Ratio | -0.41 | 1.31 | -0.20 |
| Asset Turnover | 0.50 | 0.33 | - |
| Quick Ratio | 1.35 | 1.80 | 1.14 |
| Current Ratio | 1.47 | 1.85 | 1.29 |
| Return on Equity (ROE) | -110.51% | -48.32% | - |
| Return on Assets (ROA) | -11.81% | -9.70% | - |
| Return on Capital Employed (ROCE) | -22.50% | -17.30% | -44.70% |
| Buyback Yield / Dilution | -6.13% | -0.94% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.